Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SepTiC: Sepsis Trials in Critical Care
ISRCTN80791572Phase 4Recruiting
- Sponsor
- Imperial College London
- Start
- Jan 2023
- Modality
- Recombinant Proteins and Enzymes
01
Overview
Phase 4, randomised, open-label trial of sargramostim in sepsis (6 arms), sponsored by Imperial College London. Started Jan 2023; status: recruiting.
02
Drugs
sargramostim
03
Conditions
sepsis
Beyond the preview
Go deeper on ISRCTN80791572.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN80791572.